Contineum Therapeutics, Inc. - Class A Common Stock, $0.001 par value per share (CTNM)

CUSIP: 21217B100

Q4 2025 13F Holders as of 31 Dec 2025

Type / Class
Equity / Class A Common Stock, $0.001 par value per share
Shares outstanding
30,273,764
Total 13F shares
29,575,131
Share change
+12,033,429
Total reported value
$337,955,086
Put/Call ratio
137%
Price per share
$11.43
Number of holders
79
Value change
+$137,435,356
Number of buys
57
Number of sells
19

Quarterly Holders Quick Answers

What is CUSIP 21217B100?
CUSIP 21217B100 identifies CTNM - Contineum Therapeutics, Inc. - Class A Common Stock, $0.001 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Contineum Therapeutics, Inc. - Class A Common Stock, $0.001 par value per share (CTNM) as of Q4 2025

As of 31 Dec 2025, Contineum Therapeutics, Inc. - Class A Common Stock, $0.001 par value per share (CTNM) was held by 79 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 29,575,131 shares. The largest 10 holders included SUVRETTA CAPITAL MANAGEMENT, LLC, JANUS HENDERSON GROUP PLC, RA CAPITAL MANAGEMENT, L.P., JOHNSON & JOHNSON, FRANKLIN RESOURCES INC, Balyasny Asset Management L.P., PERCEPTIVE ADVISORS LLC, BAKER BROS. ADVISORS LP, VANGUARD GROUP INC, and MILLENNIUM MANAGEMENT LLC. This page lists 79 institutional shareholders reporting positions in this security for the Q4 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.